Skip to content

Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions

Coping After Breast Cancer - CABC - Stressmestring Etter Brystkreft - SEB

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04480203
Acronym
CABC
Enrollment
390
Registered
2020-07-21
Start date
2021-01-15
Completion date
2035-12-31
Last updated
2022-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Patients, Health, Subjective

Keywords

Health Related Quality of Life, Stress management intervention

Brief summary

1. Breast cancer patients and age-matched controls are first invited to answer questions on HRQoL. 2. Among responding breast cancer patients, a subset are invited in a randomized clinical trial with two digital interventions for cancer stress management, cognitive based stress management (CBSM) and mindfulness based intervention (MBI), as well as a control group. 3. The goal is to determine whether digital CBSM or MBI can effectively reduce stress levels as compared to a control group. Second, whether these interventions can improve HRQoL (or avoid onset of HRQoL problems) for patients with breast cancer, compared to a control group.

Detailed description

After completing the baseline HRQoL assessment, eligible breast cancer patients will be invited to participate in a randomized clinical trial. Those who are willing will be randomly allocated to one of the following arms: a) Digital cognitive based stress management, b) Digital mindfulness based intervention or c) Control group. The intervention is based on a revised version of the Stressproffen app, which was developed by the Oslo University Hospital (Lise Solberg Nes, Elin Børøsund and others). Outcome measures include measures of perceived stress and HRQoL.

Interventions

OTHERStressproffen cognitive based stress management

The participants will download an app (Stressproffen 2A) with cognitive based stress management.

OTHERStressproffen mindfulness based intervention

The participants will download an app (Stressproffen 2B) with mindfulness based intervention.

OTHERControl

The participants will receive no app. (They will be able to download it after the end of the 3 year study).

Sponsors

Norwegian Institute of Public Health
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Only the staff that have contact with the participants will know who receives which intervention. The statistician and investigators will be masked.

Intervention model description

An intervention study of breast cancer patients with two digital intervention arms and one control group.

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* first occurrence breast cancer diagnosed from Jan 1, 2020 * non-metastatic cancer stage 0-III Invasive tumors must be: * HER2 positive (regardless of ER, PR) or * ER negative * (may later include other ER+ if not conflict with recruitment for EMIT/OPTIMA)

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Stresschange from CABC baseline (week 0) to f-up week 21Cohens perceived stress scale. Unit is summary score.

Secondary

MeasureTime frameDescription
Copingchange from CABC baseline (week 0) to f-up week 21TOMCATS questionnaire. Unit is summary score.
Anxiety and depressionchange from CABC baseline (week 0) to f-up week 21PHQ-4 questionnaire. Unit is summary score.
Fatiguechange from CABC baseline (week 0) to f-up week 21Chalders' fatigue questionnaire. Unit is summary score.
Mindfulnesschange from CABC baseline (week 0) to f-up week 21Baer 2006 mindfulness questionnaire. Unit is summary score.
Sleepchange from CABC baseline (week 0) to f-up week 21selected questions fro SUSSH questionnaire. Unit is summary score.
Subjective health (HRQoL)change from CABC baseline (week 0) to f-up week 21RAND-36 questionnaire. Unit is summary score and module-specific scores
EORTC QLQ-BR23From NBCR baseline to f-up week 20EORTC breast cancer questionnaire. Unit is summary score.
Neuropathy (FACT GOG-NTX and -ES)From NBCR baseline to f-up week 20neuropathy questionnaire. Unit is summary score.
Stresschange from CABC baseline (week 0) to f-up month 15Cohens perceived stress scale. Unit is summary score.
Workstatus at f-up month 15questions on employment. Whether employed and percentage
EORTC QLQ-C30From NBCR baseline to f-up week 20EORTC health related quality of life (HRQoL) general questionnaire. Unit is summary score.

Countries

Norway

Contacts

Primary ContactGiske Ursin, MD, PhD
giske.ursin@kreftregisteret.no+4722451300
Backup ContactIne M Larsson
ine.marie.larsson@kreftregisteret.no+4722928985

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026